In memoriam: Jan van Eys
Jan van Eys, a physician–scientist who pioneered the use of chemotherapy as a primary intervention for pediatric brain tumors, died Sept. 24 at the age of 93. He joined the American Society for Biochemistry and Molecular Biology in 1960 and was a member for more than 60 years.

Born January 25, 1929 in the Netherlands, van Eys immigrated to the United States in 1951 after living through World War II and German occupation. In an interview with the University Club of Nashville in 2018, he said he came to the U.S. because he was “young, adventuresome and rebellious” and wanted to pursue a Ph.D. in biochemistry at Vanderbilt University, which he earned in 1955. He also completed his postdoctoral training at Vanderbilt while researching enzymology and metabolic regulation. He went on to earn an M.D. from the University of Washington in 1966.
As a physician–scientist at Vanderbilt, van Eys established a pediatric hemophilia and hematology specialty and completed foundational research on pyruvate kinase deficiency and hemophilia. In 1973, he moved to the University of Texas M.D. Anderson Cancer Center and became the chair of pediatrics, making substantial contributions to the field of pediatric oncology. After retiring in 1994, he continued to teach ethics courses to medical and graduate students.
van Eys was a member of the institutional review boards at Vanderbilt University and Centerstone, a national health system that provides mental health and substance use disorder treatments. He was also a member of the board of the Tennessee Hemophilia and Bleeding Disorder Foundation and the board of the National Hemophilia Foundation.
He is survived by his partner, Judith Hodges; daughter, Dickey Catherine van Eys Fuchs; son, Jan Peter van Eys, and his wife, Patti; three grandsons; and two great-granddaughters.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.